인투셀 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이향숙, was filed 05 Jun 2026.
인투셀: what insiders have been doing
인투셀, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 1 November 2026, brought 5 filings signed by 4 insiders.
Every open-market trade in the period is a purchase: 4 purchases, from 3 insiders, and not a single sale. No amount is published for 4 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 3 senior executives among the declarants.
With 5 filings in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2025, the database holds 13 purchases and 1 sale by insiders of the company.
The last purchase on record was published on 5 June 2026, which is 158 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySale+2 other insiders
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 7,092 sharesShareKRXDART:20260605000518Canonical exit: 3 Sept 2026 (T+90)
- 7,428 sharesShareKRXDART:20260605000524Canonical exit: 3 Sept 2026 (T+90)
- ●Executives0DART
- 1,060 sharesShareKRXDART:20260202001269Canonical exit: 3 May 2026 (T+90)
- 3,300 sharesShareKRXDART:20251224000270Canonical exit: 24 Mar 2026 (T+90)
- 35,772 sharesKRXDART:20250707000184
- 707,993 sharesKRXDART:20250530002548Canonical exit: 21 Aug 2025 (T+90)
- 861,587 sharesKRXDART:20250529000443Canonical exit: 21 Aug 2025 (T+90)
- 3,856,762 sharesKRXDART:20250529000311Canonical exit: 21 Aug 2025 (T+90)
- 285,040 sharesShareKRXDART:20250528000208Canonical exit: 26 Aug 2025 (T+90)
- 76,400 sharesShareKRXDART:20250528000206Canonical exit: 26 Aug 2025 (T+90)
- 40,400 sharesShareKRXDART:20250528000247Canonical exit: 26 Aug 2025 (T+90)
- 207,960 sharesShareKRXDART:20250528000244Canonical exit: 26 Aug 2025 (T+90)
- 144,000 sharesShareKRXDART:20250528000194Canonical exit: 26 Aug 2025 (T+90)
- 2,900,000 sharesShareKRXDART:20250528000167Canonical exit: 26 Aug 2025 (T+90)
15 of 15 declarations
About 인투셀
인투셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for disease treatment.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
